|
|
|
| Measurement of thyroid 131I activity in 162 iodine treatment workers in Hubei Province, China |
| SUN Gangtao1, WANG Fang1, ZHANG Jianfeng2, LI Xiaoliang2, ZHAI Hezheng3, ZHOU Wenshan1 |
1. Hubei Provincial Center for Disease Control and Prevention, Wuhan 430079 China;
2. National Institute for Radiological Protection, China Center for Disease Control and Prevention, Beijing 100088 China;
3. Institute of Radiation Medicine Chinese Academy of Medical Sciences, Tianjin 300192 China |
|
|
|
|
Abstract Objective To determine the current status of occupational internal exposure to 131I in the thyroid of nuclear medicine workers, to explore the influencing factors for internal exposure, and to provide a basis for the radiation safety management of nuclear medicine. Methods The cluster sampling method was used to select 162 workers practicing 131I treatment in 24 hospitals in Hubei Province, China. Thyroid 131I activity levels were measured in vitro using a portable γ-spectrometer, and the committed effective dose was estimated. Results The thyroid 131I activity detected in 13 (54.17%) hospitals was above the lower limit of detection of the instrument. Two hospitals had the highest detection rates, 62.50% and 61.90%; the difference was significant compared with the remaining 11 hospitals (P < 0.0001). Thyroid 131I was detected in 34 workers in total, with a detection rate of 20.99% and a mean activity of 179.09 ± 138.71 (6.02-589.74) Bq. The highest detection rates were found in cleaners and nurses, which were 35.71% and 33.33%, respectively, with no significant difference in detection rate between positions (least P > 0.08). The mean value of the committed effective dose was 0.68 ± 0.52 (0.02-2.22) mSv/a in the 34 workers. Conclusion The 131I consumption and workplace ventilation may be important factors affecting the level of internal exposure. It is important to strengthen the training of nuclear medicine workers on radioprotection and workflow management, as well as the regular monitoring of occupational internal exposure for 131I treatment-related workers.
|
|
Received: 14 January 2023
|
|
|
|
|
|
[1] 吴茜, 王荣福. 放射性核素131I在甲亢治疗中的应用现状和进展[J]. 标记免疫分析与临床,2015,22(1):66-68. DOI: 10.11748/bjmy.issn.1006-1703.2015.01.021
Wu Q, Wang RF. Overview and progress of 131I in the treatment of hyperthyroidism[J]. Lab Immun Clin Med, 2015, 22(1): 66-68. DOI: 10.11748/bjmy.issn.1006-1703.2015.01.021
[2] Masiuk S, Chepurny M, Buderatska V, et al. Assessment of internal exposure to 131I and short-lived radioiodine isotopes and associated uncertainties in the Ukrainian cohort of persons exposed in utero[J]. J Radiat Res, 2022, 63(3): 364-377. DOI: 10.1093/jrr/rrac007
[3] Brudecki K, Szczodry A, Mróz T, et al. Measurement of 131I activity in air indoor Polish nuclear medical hospital as a tool for an internal dose assessment[J]. Radiat Environ Biophys, 2018, 57(1): 77-82. DOI: 10.1007/s00411-017-0724-3
[4] 中华人民共和国国家卫生和计划生育委员会. GBZ 129—2016 职业性内照射个人监测规范[S]. 北京: 中国标准出版社, 2016.
National Health and Family Planning Commission of People's Republic of China. GBZ 129—2016 Specifications for individual monitoring of occupational internal exposure[S]. Beijing: Standards Press of China, 2016.
[5] International Commission on Radiological Protection. ICRP Publication 137. Occupational intakes of radionuclides: part 3[R]. USA: SAGE, 2017.
[6] 中华医学会核医学分会. 2020年全国核医学现状普查结果简报[J]. 中华核医学与分子影像杂志,2020,40(12):747-749. DOI: 10.3760/cma.j.cn321828-20201109-00403
Chinese Society of Nuclear Medicine. A brief report on the results of the national survey of nuclear medicine in 2020[J]. Chin J Nucl Med Imaging, 2020, 40(12): 747-749. DOI: 10.3760/cma.j.cn321828-20201109-00403
[7] 彭玄, 张建峰, 拓飞, 等. 便携式γ谱仪在放射工作人员甲状腺131I监测中的应用[J]. 中国辐射卫生,2021,30(1):34-37,43. DOI: 10.13491/j.issn.1004-714X.2021.01.008
Peng X, Zhang JF, Tuo F, et al. Application of portable γ-ray spectrometer in monitoring thyroid 131I in radiation workers[J]. Chin J Radiol Health, 2021, 30(1): 34-37,43. DOI: 10.13491/j.issn.1004-714X.2021.01.008
[8] 王红波, 张钦富, 侯长松, 等. 医院核医学科工作人员内照射监测的必要性研究[J]. 中国工业医学杂志,2016,29(5):333-335,355. DOI: 10.13631/j.cnki.zggyyx.2016.05.003
Wang HB, Zhang QF, Hou CS, et al. Study on necessity of monitoring internal radiation in nuclear medicine staffs of hospital[J]. Chin J Ind Med, 2016, 29(5): 333-335,355. DOI: 10.13631/j.cnki.zggyyx.2016.05.003
[9] 王红波, 张庆召, 张震, 等. 核医学科工作人员职业性内照射研究进展[J]. 中国辐射卫生,2016,25(2):251-254. DOI: 10.13491/j.cnki.issn.1004-714X.2016.02.045
Wang HB, Zhang QF, Zhang Z, et al. Advances in the study of occupational internal exposure in nuclear medicine staff[J]. Chin J Radiol Health, 2016, 25(2): 251-254. DOI: 10.13491/j.cnki.issn.1004-714X.2016.02.045
[10] 王红波. 核医学科工作人员职业性内照射研究[D]. 北京: 中国疾病预防控制中心, 2017.
Wang HB. Study on occupational internal exposure of nuclear medicine workers[D]. Beijing: Chinese Center for Disease Control and Prevention, 2017.
[11] 李小亮, 孙伟航, 李则书, 等. 6家医院碘治疗场所工作人员甲状腺131I活度测量[J]. 中华放射医学与防护杂志,2022,42(6):448-453. DOI: 10.3760/cma.j.cn112271-20210908-00371
Li XL, Sun WH, Li ZS, et al. Measurement of 131I activity in thyroid of workers at the place of radioiodine therapy in six hospitals[J]. Chin J Radiol Med Prot, 2022, 42(6): 448-453. DOI: 10.3760/cma.j.cn112271-20210908-00371
[12] 王洁, 张涵宇, 邬家龙, 等. 甘肃省3家医院核医学科放射工作人员内照射水平分析[J]. 中国辐射卫生,2020,29(4):357-361. DOI: 10.13491/j.issn.1004-714X.2020.04.009
Wang J, Zhang HY, Wu JL, et al. Analysis of radiation internal exposure in nuclear medicine staff of three hospitals in Gansu Province[J]. Chin J Radiol Health, 2020, 29(4): 357-361. DOI: 10.13491/j.issn.1004-714X.2020.04.009
[13] 马加一, 史晓东. 体外直接检测法评估南京市3家医院核医学工作人员的内照射个人剂量水平[J]. 环境与职业医学,2019,36(6):549-553. DOI: 10.13213/j.cnki.jeom.2019.18722
Ma JY, Shi XD. Individual dose of radiation internal exposure by in vitro detection in nuclear medicine staff of three hospitals in Nanjing[J]. J Environ Occup Med, 2019, 36(6): 549-553. DOI: 10.13213/j.cnki.jeom.2019.18722
[14] 陈湃韩, 陈慧峰, 邹剑明. 低剂量电离辐射长期接触健康效应研究进展[J]. 中国辐射卫生,2022,31(1):99-104. DOI: 10.13491/j.issn.1004-714X.2022.01.018
Chen PH, Chen HF, Zou JM. Research progress in health effects of long-term exposure to low-dose ionizing radiation[J]. Chin J Radiol Health, 2022, 31(1): 99-104. DOI: 10.13491/j.issn.1004-714X.2022.01.018
[15] Lubin JH, Adams MJ, Shore R, et al. Thyroid cancer following childhood low-dose radiation exposure: a pooled analysis of nine cohorts[J]. J Clin Endocrinol Metab, 2017, 102(7): 2575-2583. DOI: 10.1210/jc.2016-3529
[16] Kitahara CM, Preston DL, Neta G, et al. Occupational radiation exposure and thyroid cancer incidence in a cohort of U. S. radiologic technologists, 1983-2013[J]. Int J Cancer, 2018, 143(9): 2145-2149. DOI: 10.1002/ijc.31270
[17] 范胜男, 王拓, 李梦雪, 等. 2017年我国放射工作人员职业性外照射个人剂量水平与分析[J]. 中华放射医学与防护杂志,2021,41(2):85-91. DOI: 10.3760/cma.j.issn.0254-5098.2021.02.002
Fan SN, Wang T, Li MX, et al. Analysis of individual doses to radiation workers from occupational external exposure in China in 2017[J]. Chin J Radiol Med Prot, 2021, 41(2): 85-91. DOI: 10.3760/cma.j.issn.0254-5098.2021.02.002
[18] Portela T, Camozzato TSC, de Cássia Flôr R, et al. Occupational exposure in the working process of radiological nursing in nuclear medicine[J]. J Radiol Nurs, 2021, 40(3): 246-253. DOI: 10.1016/j.jradnu.2021.02.005
[19] Miszczyk J, Rawojć K, Panek A, et al. Assessment of the nuclear medicine personnel occupational exposure to radioiodine[J]. Eur J Radiol, 2019, 121: 108712. DOI: 10.1016/j.ejrad.2019.108712
[20] Brudecki K, Kluczewska-Galka A, Mróz T, et al. 131I internal contamination and committed dose assessment among nuclear medicine medical personnel[J]. Radiat Prot Dosim, 2018, 179(3): 275-281. DOI: 10.1093/rpd/ncx274
|
|
|
|
